| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |